ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

E-ISSN： 1875-6166|6|3|193-210

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.6, Iss.3, 2006-09, pp. : 193-210

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-Ribosyl)ation Enzyme-1 as a Target for Neuroprotection in Acute Central Nervous System Injury

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 5, 2003-10 ,pp. : 279-291

Bentham Science Publishers

Access to resources Recommend Favorite

Alpha7 Neuronal Nicotinic Receptor: A Pluripotent Target for Diseases of the Central Nervous System

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 5, 2014-06 ,pp. : 836-845

Bentham Science Publishers

Access to resources Recommend Favorite

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite

Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury

Current Pharmaceutical Design, Vol. 13, Iss. 24, 2007-08 ,pp. : 2507-2518

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Therapeutic Options in Central Nervous System Involvement of Rheumatologic Diseases (Executive Editor: Ali Gur)]

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1240-1241

Bentham Science Publishers

Access to resources Recommend Favorite